$100K investment made to Confluence Pharmaceuticals, seeking to treat autism, fragile X symptoms,

Continued work and research are preparing the company for Phase II clinical trials for its treatment of fragile X syndrome and its next round of financing., Continued work and research are preparing the company for Phase II clinical trials for its treatment of fragile X syndrome and its next round of financing., Read More

Scroll to Top